WeightWatchers gets into prescription weight loss business
The Associated Press
WeightWatchers’ stock is soaring after the company said it is getting into the prescription drug weight loss business with the acquisition of Sequence.
The telehealth operator can prescribe medications under brand names including Ozempic, Wegovy and Trulicity.
WeightWatchers offers subscribers meal plans with the goal of losing excess weight.
With the acquisition of Sequence, the company is tapping into a red-hot market for prescription drugs that address obesity, and broadening what it offers to customers.
Shares of New York-based WW International Inc. rose 79% on Tuesday.
Read the full story on AP News right here.
(Copyright 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
3/7/2023 5:20:33 PM (GMT -6:00)